Publications by authors named "Shawn Heidel"

Claim this Profile
C
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use.
Fiona Sewell, Kathryn Chapman, Jessica Couch, Maggie Dempster, Shawn Heidel

MAbs· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulation and lymphoma in humans.
Rafael A Ponce, Thomas Gelzleichter, Helen G Haggerty, Shawn Heidel, Matthew S Holdren

J Immunotoxicol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High molecular weight polyethylene glycol cellular distribution and PEG-associated cytoplasmic vacuolation is molecular weight dependent and does not require conjugation to proteins.
Daniel G Rudmann, James T Alston, Jeffrey C Hanson, Shawn Heidel

Toxicol Pathol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.
John L Vahle, Gregory L Finch, Shawn M Heidel, David N Hovland, Inge Ivens

Toxicol Pathol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety assessment of biopharmaceuticals: Japanese perspective on ICH S6 guideline maintenance.
Takahiro Nakazawa, Misao Kurokawa, Kazuya Kimura, Akihiro Wakata, Shigeru Hisada, Shawn M Heidel

J Toxicol Sci· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?
Janet Clarke, Christopher Hurst, Pauline Martin, John Vahle, Rafael Ponce, Shawn Heidel

Regul Toxicol Pharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 6-month inhalation study to characterize the toxicity, pharmacokinetics, and pharmacodynamics of human insulin inhalation powder (HIIP) in beagle dogs.
Andrew Vick, Ronald Wolff, Alan Koester, Rachel Reams, Daniel R Deaver, Shawn Heidel

J Aerosol Med· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis